HUTCHMED (China) Limited - ADR Live Stock Price Today, Share Analysis and Chart

Name: HUTCHMED (China) Limited - ADR: Is Infosys Ltd. worth buying?
Item: HUTCHMED (China) Limited - ADR
Rating: 1.21150
Author: Trendlyne DVM scores

about

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several...

14.83 -0.13 (-0.87%)

31.02% Fall from 52W High

45,090

XNAS Volume

XNAS 28 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

6.5 / 100

Technically Neutral

42.0 / 100

1Yr Price target upside is 54%

15 analysts

HUTCHMED (China) Limited -... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

HUTCHMED (China) Limited - ADR Live Stock Price Today, Share Analysis and Chart

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several...

31.02% Fall from 52W High

SWOT Analysis

HUTCHMED (China) Limited -... Live Price Chart